NCT01478022View on ClinicalTrials.gov

To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Duchenne Muscular Dystrophy (DMD)
Interventions
DRUG

Isosorbide Dinitrate

Isosorbide Dinitrate 10 mgx2, daily, capsules

DRUG

Ibuprofen

Ibuprofen 200 mg daily, capsules

OTHER

Ibuprofen and Isosorbide Dinitrate combination

Ibuprofen 200 mg and Isosorbide Dinitrate 20 mg combination daily dose

Trial Locations (1)

20157

Clinical Phase 1 Unit - Luigi Sacco Hospital, Milan

All Listed Sponsors
lead

Parent Project, Italy

OTHER

NCT01478022 - To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20 | Biotech Hunter | Biotech Hunter